Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zai Lab (ZLAB) Gains from Investment Securities (2020 - 2025)

Zai Lab's Gains from Investment Securities history spans 7 years, with the latest figure at $8.2 million for Q3 2025.

  • For Q3 2025, Gains from Investment Securities rose 982.03% year-over-year to $8.2 million; the TTM value through Dec 2025 reached $8.2 million, up 469.9%, while the annual FY2025 figure was $8.2 million, 469.9% up from the prior year.
  • Gains from Investment Securities for Q3 2025 was $8.2 million at Zai Lab, up from $1.4 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $8.2 million in Q3 2025 and bottomed at -$7.7 million in Q4 2022.
  • The 5-year median for Gains from Investment Securities is $188000.0 (2021), against an average of $707722.2.
  • The largest YoY upside for Gains from Investment Securities was 115000.0% in 2022 against a maximum downside of 26558.62% in 2022.
  • A 5-year view of Gains from Investment Securities shows it stood at -$29000.0 in 2021, then plummeted by 26558.62% to -$7.7 million in 2022, then skyrocketed by 104.81% to $372000.0 in 2023, then rose by 21.77% to $453000.0 in 2024, then skyrocketed by 1708.17% to $8.2 million in 2025.
  • Per Business Quant, the three most recent readings for ZLAB's Gains from Investment Securities are $8.2 million (Q3 2025), $1.4 million (Q2 2025), and -$1.4 million (Q1 2025).